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severe vitamin D deficiency. The use of vitamin D, alcohol 
consumption and higher average daily sun exposure were 
independent protective factors against (severe) vitamin D 
deficiency.
Conclusion Given the potential role of vitamin D in 
fracture healing, clinicians treating adult fracture patients 
should be aware of the frequent presence of vitamin D 
deficiency during the winter, especially in smoking and 
non-Caucasian patients. Research on the effect of vita-
min D deficiency or supplementation on fracture heal-
ing is needed, before suggesting routine monitoring or 
supplementation.
Keywords Vitamin D · Vitamin D deficiency · Risk 
factors · Fracture · Fracture healing
Introduction
Vitamin D is acquired through nutritional uptake and by the 
cutaneous synthesis under the influence of UV radiation. 
Vitamin D status has been associated with cancer, immune 
deregulation, diabetes mellitus, cardiovascular health, mus-
cle function and mental health [1]. Vitamin D is also essen-
tial for the development and maintenance of mineralized 
bone [2]. It plays a significant role in the complex cellular 
processes of fracture healing [3]. Although animal stud-
ies suggest that a deficiency may hamper fracture healing, 
human studies that address the clinical effects of vitamin 
D deficiency or supplementation on fracture healing are 
scarce and remain inconclusive [3].
The prevalence of vitamin D deficiency is considered 
a global health problem [4, 5]. In fracture patients, most 
studies focus on the elderly with hip fractures and predomi-
nantly osteoporotic fractures. These studies found a vitamin 
Abstract 
Purpose Although vitamin D levels are not routinely 
monitored in outpatient fracture patients, identification of 
fracture patients with a deficient vitamin D status may be 
clinically relevant because of the potential role of vitamin 
D in fracture healing. This study aimed to determine the 
prevalence of and risk factors for vitamin D deficiency in 
non-operatively treated adult fracture patients.
Patients and methods Vitamin D levels were determined 
in a cross-sectional study of adult patients, who were 
treated non-operatively for a fracture of the upper or lower 
extremity in the outpatient clinic of a level 1 trauma center, 
during one calendar year. Potential risk factors for (severe) 
vitamin D deficiency were analyzed using multivariable 
logistic regression analysis.
Results A total of 208 men and 319 women with a mean 
age of 49.7 years (SD 19.9) were included. In this popula-
tion, 71 % had a serum calcidiol <75 nmol/L, 40 % were 
vitamin D deficient (serum calcidiol <50 nmol/L) and 
11 % were severely vitamin D deficient (serum calcidiol 
<25 nmol/L). Smoking and season (winter and spring) 
were independent risk factors for vitamin D deficiency. 
An increasing age, a non-Caucasian skin type, winter and 
smoking were identified as independent risk factors for 
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D deficiency (serum calcidiol <50 nmol/L) prevalence var-
ying between 22 and 100 % [6–30]. Studies in non-hip or 
osteoporotic fracture patients found vitamin D prevalences 
of 13–50 % [31–36].
Currently, vitamin D status is not routinely monitored 
in outpatient fracture patients. Given the potential role 
that vitamin D has in fracture healing, it might be clini-
cally relevant to identify fracture patients who are at risk 
for vitamin D deficiency. The aim of the present study was 
to determine the prevalence of vitamin D deficiency and 
identify risk factors for vitamin D deficiency in outpatient 
adult fracture patients that were treated non-operatively for 
a fracture of the upper or lower extremity.
Patients and methods
Study design and participants
Approval for this cross-sectional study was obtained from 
the institutional Medical Ethics Review Committee. All 
consecutive adult patients (≥18 years) with conservatively 
treated fractures of the upper or lower extremity, in the out-
patient clinic of our level 1 trauma center between 1 Sep-
tember 2012 and 1 October 2013, were informed about the 
study. They were asked to participate within 1 week after 
the fracture had occurred and to provide written informed 
consent. After the patient’s consent was obtained, blood 
was taken, a questionnaire was filled out, and demographic 
and fracture characteristics were documented.
Procedures
Blood was taken during the first outpatient control. The 
serum concentration calcidiol was measured using an elec-
trochemiluminescence immunoassay (ECLIA) from Roche 
Diagnostics (Modular E170). The vitamin D serum con-
centration was defined as sufficient if the serum calcidiol 
level was ≥75 nmol/L (30 ng/ml); insufficient if the level 
was between 50 and 75 nmol/L; deficient if the level was 
<50 nmol/L (20 ng/ml) and severely deficient if the serum 
level was <25 nmol/L (10 ng/ml) [1, 37–40].
Included patients, unaware of their vitamin D status, 
completed a questionnaire on potentially relevant factors 
for vitamin D deficiency including medical history, medica-
tion and vitamin D usage prior to fracture. In the question-
naire, daily UV radiation exposure was defined as the aver-
age number of hours spent outdoors between 10.00 a.m. 
and 15.00 p.m. [1, 37, 40]. Also, the use of a solarium was 
questioned. Skin type was determined using the Fitzpatrick 
scale [41] (Type I: pale white skin, always burns, never 
tans; Type II: white skin, burns easily, tans minimally; Type 
III: white skin, burns moderately, tans uniformly; Type IV: 
light brown/moderate brown skin, burns minimally, always 
tans well; Type V: brown, rarely burns, tans profusely. Type 
VI: dark brown to black skin, never burns).
Statistical analysis
Patient characteristics are presented as mean and standard 
deviation (SD) or as number (%). Patient groups were com-
pared using the Student’s t test for continuous variables and 
the Chi-square test or Fisher’s exact test (when the expected 
count in any of the cells of the 2 × 2 contingency table 
was <5) for categorical data. Patient characteristics with 
a univariable association (p ≤ 0.10) with (severe) vitamin 
D deficiency were combined in a forward stepwise multi-
variable logistic regression analysis to identify independent 
risk factors for these conditions (p-to-enter <0.05 and p-to-
remove >0.10). The predictive value of selected potential 
risk factors was expressed as the adjusted odds ratio (OR) 
with its corresponding 95 % confidence interval (CI). Sta-
tistical analysis was performed with SPSS software version 
20 (SPSS, Inc., Chicago, IL, USA). p values <0.05 were 
considered to be statistically significant.
Results
Patient characteristics
A total of 902 patients, 412 men and 490 women (54 %) 
with a mean age of 47.8 years (SD 21.3), were eligible and 
approached for participation. Of these, 208 men and 319 
women (61 %) with a mean age of 49.7 years (SD 19.9) 
agreed to participate. The most frequently encountered rea-
sons for non-participation included reluctance to undergo a 
venipuncture and participation in another study.
The vast majority of the 551 fractures in the 527 included 
patients were located in the upper extremity (71 %). The 
most frequent fractures were distal radius fractures (33 %; 
Fig. 1), followed by metatarsal (13 %) and metacarpal frac-
tures (12 %). In the non-participating patient group, the 
fracture (n = 376) distribution was similar: 287 fractures 
were located in the upper extremity (76 %), 27 % in the 
distal radius, 21 % in the metacarpal bones and 10 % in the 
metatarsal bones.
Of the 527 patients, 101 (19 %) had no previous med-
ical history, 216 (41 %) did not use any medication and 
117 (22 %) used vitamin D supplements, in some cases in 
combination with calcium or as a component in a multi-
vitamin (Table 1). Most patients, 482 (92 %), had a white 
skin type (I–III), 38 patients (7 %) had skin type IV and 
only 4 (1 %) had skin type V or VI. The average sun expo-
sure between 10.00 a.m. and 15.00 p.m. was 1.9 h per day 
(SD 1.2).
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The blood sample was taken at a median period of 
7 days after fracture (range 0–85 days). The mean concen-
tration serum calcidiol was 59·5 nmol/L (SD 29.4, range 
8–175). A minority of 151 (29 %) patients had a sufficient 
calcidiol level, 166 patients (31 %) had insufficient levels 
(50–75 nmol/l) and 210 patients (40 %) had a vitamin D 
deficiency (calcidiol <50 nmol/L), of whom 58 patients 
(11 % of the total group) had a severe vitamin D defi-
ciency. The highest prevalence of vitamin D deficiency 
was observed during the winter and spring (53 %; Fig. 2).
Risk factors for vitamin D deficiency: calcidiol 
<50 nmol/L
Potential risk factors for vitamin D deficiency (uni-
variable p ≤ 0.10) were male gender, older age, body 
mass index (BMI) ≥30, non-Caucasian skin type (skin 
type IV, V, VI), diabetes mellitus, use of antihyperten-
sive medication or nonsteroidal antiinflammatory drugs 
(NSAIDs), smoking and season (winter and spring) 
(Table 1). Potentially protective factors against vita-
min D deficiency were the use of vitamin D, alcohol 
consumption, more daily sun exposure and the use of a 
solarium or a holiday with high sun exposure within the 
previous month.
In the multivariable logistic regression model, independ-
ent and statistically significant risk factors for vitamin D 
deficiency were smoking (OR 2.02) and season (winter OR 
2.44 and spring OR 3.07) (Table 2). Independent protec-
tive factors against vitamin D deficiency were the use of 
vitamin D (OR 0.46), alcohol consumption (OR 0.47 and 
0.26 respectively for ≤2 and >2 units per day), more daily 
sun exposure (OR 0.77 per additional hour) and a recent 
holiday with a high sun exposure (OR 0.43).
Fig. 1  Number of fractures 
specified by location; 551 frac-
tures in total
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Table 1  Patient characteristics and their univariable association with vitamin D deficiency (calcidiol <50 mol/L) and severe vitamin D defi-
ciency (calcidiol <25 mol/L)
Characteristic Total
n = 527 (%)
Vitamin D deficiency Severe vitamin D deficiency
Yes
n = 210 (%)
No
n = 317 (%)
p Yes n = 58 (%) No n = 469 (%) p
Gender
 Female 319 (61) 118 (37) 201 (63) 0.10 33 (10) 286 (90) 0.55
 Male 208 (39) 92 (44) 116 (56) 25 (12) 183 (88)
Age in years, mean (SD) 49.7 (19.9) 51.5 (20.5) 48.6 (19.5) 0.10 53.8 (20.7) 49.2 (19.8) 0.10
BMI
 Normal/overweight; BMI <30 433 (82) 162 (37) 271 (63) 0.05 47 (11) 386 (89) 0.85
 Obesity; BMI ≥30 71 (14) 37 (52) 34 (48) 9 (13) 62 (87)
 Unknown 23 (4) 11 (48) 12 (52) 2 (9) 21 (91)
Skin type
 Caucasian (type I, II, III) 482 (92) 187 (39) 295 (61) 0.04 47 (10) 435 (90) 0.003
 Non-Caucasian (type IV, V, VI) 42 (8) 23 (45) 19 (55) 11 (26) 31 (74)
Medical history
 Medical history
  Yes 426 (81) 176 (41) 250 (59) 0.16 47 (11) 379 (89) 0.97
  No 101 (19) 34 (34) 67 (66) 11(11) 90 (89)
 Previous fracture
  Yes 270 (51) 109 (40) 161 (60) 0.77 32 (12) 238 (88) 0.57
  No 253 (49) 99 (39) 154 (61) 26 (10) 227 (90)
 Hypertension
  Yes 85 (16) 34 (40) 51 (60) 0.98 8 (9) 77 (91) 0.61
  No 442 (84) 176 (40) 266 (60) 50 (11) 392 (89)
 Diabetes mellitus
  Yes 22 (4) 13 (59) 9 (41) 0.06 3 (14) 19 (86) 0.72
  No 505 (96) 197 (39) 308 (61) 55 (11) 450 (89)
 Depression
  Yes 20 (4) 8 (40) 12 (60) 0.99 4 (20) 16 (80) 0.19
  No 507 (96) 202 (40) 305 (60) 54 (11) 305 (98)
 Osteoporosis
  Yes 13 (2) 3 (23) 10 (77) 0.21 2 (15) 11 (85) 0.64
  No 514 (98) 207 (40) 307 (60) 56 (11) 458 (89)
Use of medication
 Vitamin D
  Yes 117 (22) 31 (27) 86 (73) 0.001 5 (4 %) 112 (96) 0.008
  No 408 (78) 179 (44) 229 (56) 53 (13) 355 (87)
 Antihypertensive
  Yes 103 (20) 51 (50) 52 (50) 0.03 13 (13) 90 (87) 0.56
  No 424 (80) 159 (38) 265 (62) 45 (11) 379 (89)
 NSAID
  Yes 34 (6) 20 (59) 14 (41) 0.02 7 (21) 27 (79) 0.08
  No 493 (94) 190 (39) 303 (61) 51 (10) 442 (90)
 Antidepressive
  Yes 21 (4) 9 (43) 12 (57) 0.77 3 (14) 18 (86) 0.50
  No 506 (96) 201 (40) 305 (60) 55 (11) 451 (89)
 Oral antidiabetics or insulin
  Yes 20 (4) 11 (55) 9 (45) 0.16 2 (10) 18 (90) 1.00
  No 507 (96) 199 (39) 308 (61) 56 (11) 451 (89)
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Table 1  continued
Characteristic Total
n = 527 (%)
Vitamin D deficiency Severe vitamin D deficiency
Yes
n = 210 (%)
No
n = 317 (%)
p Yes n = 58 (%) No n = 469 (%) p
 Corticosteroids
  Yes 13 (3) 6 (46) 7 (56) 0.64 2 (15) 11 (85) 0.64
  No 514 (97) 204 (40) 310 (60) 56 (11) 458 (89)
Intoxication
 Smoking
  Yes 122 (24) 62 (51) 60 (49) 0.005 24 (20) 98 (80) 0.001
  No 394 (76) 144 (37) 250 (63) 33 (8) 361 (92)
 Alcohol consumption None 200 (39) 102 (51) 98 (49) <0.001 34 (17) 166 (83) 0.002
 Alcohol consumption ≤2 U/day 274 (53) 96 (35) 178 (65) 21 (8) 253 (92)
 Alcohol consumption >2 U/day 45 (9) 10 (22) 35 (78) 2 (4) 43 (96)
Sun exposure
 No. of hours/day, mean (SD) 1.9 (1.2) 1.7 (1.1) 2.1 (1.2) <0.001 1.6 (1.0) 1.9 (1.2) 0.02
 Use of solarium
  Yes 37 (7) 7 (19) 30 (81) 0.007 1 (3) 36 (97) 0.11
  No 480 (93) 199 (41) 281 (59)
 Vacation in the prior 4 weeks
  Yes 60 (12) 11 (18) 49 (82) <0.001 2 (3) 58 (97) 0.04
  No 459 (88) 195 (42) 264 (58)
Season of inclusion
 Summer 133 (25) 39 (29) 94 (71) <0.001 10 (8) 123 (92) 0.004
 Autumn 153 (29) 44 (29) 109 (71) 9 (6) 144 (94)
 Winter 122 (23) 64 (53) 58 (47) 22 (18) 100 (82)
 Spring 119 (23) 63 (53) 56 (47) 17 (14) 102 (86)
Results are presented as number (% of non-missing cases) unless indicated otherwise
SD standard deviation, BMI body mass index, NSAID nonsteroidal antiinflammatory drug

















Fig. 2  Vitamin D status in adult fracture patients by season: summer (June–August), autumn (September–November), winter (December–Feb-
ruary) and spring (March–May)
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Table 2  Multivariable 
logistic regression analysis 
including potential risk factors 
(univariable p ≤ 0.10) for 
vitamin D deficiency (calcidiol 
<50 mol/L) and severe vitamin 
D deficiency (calcidiol 
<25 mol/L)
BMI body mass index, NSAID nonsteroidal antiinflammatory drug, OR odds ratio, CI confidence interval, 
X Not included in the analysis (univariable p > 0.10), Not included not included in the logistic regression 
model after forward stepwise selection
Characteristic Vitamin D deficiency
Adjusted OR (95 % CI)
Severe vitamin D deficiency
Adjusted OR (95 % CI)
Gender
 Women Not included –
 Men
Age
 Years 1.01 (1.00–1.02) 1.02 (1.01–1.04)
BMI
 Normal/overweight; BMI <30 Not included –
 Obese; BMI ≥30
 Unknown
Skin type
 Caucasian (type I, II, III) Not included Reference
 Non-Caucasian (type IV, V, VI) 4.07 (1.63–10.2)
Medical history
 Diabetes mellitus
  Yes Not included –
  No
Use of medication
  Vitamin D
  Yes 0.46 (0.28–0.77) 0.28 (0.10–0.79)
  No Reference Reference
 Antihypertensive
  Yes Not included –
  No
 NSAID




  Yes 2.02 (1.25–3.25) 2.79 (1.44–5.42)
  No Reference Reference
 Alcohol consumption, none Reference Reference
 Alcohol consumption ≤2 U/day 0.47 (0.31–0.71) 0.42 (0.22–0.79)
 Alcohol consumption >2 U/day 0.26 (0.11–0.62) 0.24 (0.06–1.13)
Sun exposure
 Number of hours/day 0.77 (0.65–0.92) 0.72 (0.54–0.97)
 Use of solarium
  Yes 0.40 (0.15–1.00) –
  No Reference
 Vacation in the prior 4 weeks
  Yes 0.43 (0.21–0.89) Not included
  No Reference
Season of inclusion
 Summer Reference Reference
 Autumn 1.09 (0.62–1.93) 0.81 (0.29–2.23)
 Winter 2.44 (1.36–4.38) 2.61 (1.01–6.17)
 Spring 3.07 (1.70–5.55) 2.23 (0.90–5.49)
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Risk factors for severe vitamin D deficiency: calcidiol 
<25 nmol/L
Potential risk factors for severe vitamin D deficiency (uni-
variable p ≤ 0.10) were older age, non-Caucasian skin 
type, use of NSAIDs, smoking and season (winter and 
spring) (Table 1). Potentially protective factors against 
severe vitamin D deficiency were use of vitamin D, alcohol 
consumption, more daily sun exposure and a recent holiday 
with high sun exposure.
In the multivariable logistic regression model, independ-
ent risk factors for severe vitamin D deficiency were older 
age (OR 1.02 per 1-year increase), non-Caucasian skin 
type (OR 4.07), smoking (OR 2.79) and winter (OR 2.61) 
(Table 2). Independent protective factors against severe 
vitamin D deficiency were the use of vitamin D (OR 0.28), 
limited alcohol consumption (≤2 alcohol units per day OR 
0.42) and more daily sun exposure (OR 0.72 per additional 
hour).
Discussion
Our results shows that on average in one calendar year, 
71 % of the outpatient adult fracture population had a sub-
optimal vitamin D status (calcidiol <75 nmol/L), 40 % was 
vitamin D deficient and 11 % was severely vitamin D defi-
cient. Smoking and season (winter and spring) were inde-
pendent risk factors for a vitamin D deficiency, whereas 
smoking, winter, age and a non-Caucasian skin type were 
identified as independent risk factors for severe vitamin D 
deficiency.
We defined vitamin D deficiency as a serum calcidiol 
level <50 nmol/L, and ≥75 nmol/L was considered to be 
optimal/sufficient. These commonly used cutoff values 
are based on studies evaluating the effect of calcidiol con-
centration on calcium absorption, parathyroid hormone 
synthesis suppression, maintenance of bone mineral density 
and fall/fracture prevention and other non-skeletal actions 
of vitamin D [1, 37–39, 42]. However, due to the incon-
sistent evidence regarding these effects, there is no con-
sensus in literature on these definitions [1, 4, 37, 43–46]. It 
has also been suggested that a serum calcidiol >50 nmol/L 
could be sufficient.
Compared to other studies in non-hip or osteoporotic 
fracture patients, we found seeming differences in preva-
lence (Table 3). Briggs et al. [33] found a vitamin D defi-
ciency in 14/28 fracture patients in London between April 
and October. In our region (latitude 52°N) we found a 
33 % deficiency prevalence during these months. Bee 
et al. [34] measured a serum calcidiol <50 nmol/L in 28 % 
of their operated fracture population, 32/103 (31 %) dur-
ing the winter (January, February and March) and 24/98 
(26 %) during summer (July, August and September). In 
these periods, 50 and 24 % of our patients were deficient, 
respectively. Wright et al. [31] found in 18/37 (49 %) male 
patients with a distal forearm fracture living in Northern 
Ireland a vitamin D deficiency. Of the 49 male patients with 
a distal forearm fracture in our study, 20 (41 %) were vita-
min D deficient. Smith et al. [35] found a deficiency only in 
10/75 (13 %) patients with an ankle fracture, as compared 
to 53 % of the patients with an ankle fracture in our study. 
Four of our seven patients with patellar fractures were vita-
min D deficient, where Reinhardt et al. [36] found a prev-
alence of 33 %. Bogunovic et al. [32] also found a 40 % 
vitamin D deficiency in their operated trauma patients, 
and 94/121 patients had a lower extremity fracture. These 
seeming differences in prevalence may have resulted from 
seasonal differences and differences in geographical distri-
bution or latitude [1, 4], but may also be caused by differ-
ences in other characteristics of the study populations and 
by statistical imprecision. Nonetheless, clinicians should be 
aware that patients living north of 35 degrees latitude pro-
duce little or no vitamin D from November to February due 
Table 3  Prevalence of vitamin D deficiency (calcidiol <50 mol/L) in adult fracture patients
UK United Kingdom, USA United States of America
References Year Location—latitude Fracture population n Mean age Vitamin D 
deficiency (%)
Bee et al. [34] 2013 USA; 42–44°N Operated traumatic fractures in the upper and 
lower extremities
201 56 28
Briggs et al. [33] 2013 UK; 51°N Operated and non-operated long bone fractures 33 53 50
Bogunovic et al. [32] 2010 USA; 41°N Operated traumatic fractures in the upper and 
lower extremities
121 63 40
Bogunovic et al. [32] 2010 USA; 41°N Operated distal radial or ulnar fracture 43 66 16
Reinhardt et al. [36] 2012 USA; 41°N Operated patella fractures 30 58 33
Smith et al. [35] 2013 USA; 42°N Ankle fractures 75 52 13
Wright et al. [31] 2007 UK; 55°N Forearm fracture in males 37 54 49
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to the scarce sunlight [1], and uptake from food is generally 
insufficient to retain adequate serum concentrations of vita-
min D [37]. Consequently, active supplementation is the 
only way for vitamin D-deficient patients to complement 
their deficiency during the winter months.
Given the role of vitamin D in the maintenance of bone 
health, it could be hypothesized that vitamin D deficiency 
might be more prevalent in a fracture population than in 
the general population. However, the prevalence of 40 % 
in our fracture population was relatively low compared to 
estimates in the general Dutch population (43–71 %) [47–
49]. Well-known causes of vitamin D deficiency include 
reduced skin synthesis (skin type, sun exposure, aging, 
season and latitude), decreased bio-availability (malabsorp-
tion, obesity), decreased synthesis (liver failure), increased 
catabolism and increased urinary loss [1]. Of these causes, 
the predictive value of skin type, sun exposure, aging, sea-
son and obesity was analyzed and confirmed in our study, 
although statistical significance could not demonstrate all 
parameters. This may be due to the small patient numbers 
for some subgroups such as obese patients and patients 
with a non-Caucasian skin type.
In concordance with the results of earlier studies [35, 50, 
51], vitamin D deficiency was more prevalent in smokers in 
our study. Smoking has been shown to delay fracture heal-
ing in animal and human studies and nicotine is thought 
to inhibit the vascularization of bone and diminish osteo-
blast function [52]. On the other hand, vitamin D has been 
shown to modulate the synthesis of vascular growth factors 
[53] and functioning of osteoblasts [54, 55]. The combina-
tion of the direct (vascularization) and indirect effects (vita-
min D deficiency) of smoking might substantially increase 
the risk for impaired bone healing, although this hypothesis 
is still to be confirmed in further research.
A striking finding was that the use of alcohol was asso-
ciated with a reduced risk of vitamin D deficiency in our 
study group. This association has been found in other stud-
ies [50], whereas other studies did not find any association 
[49, 56–59], or a negative association [60–62]. As yet, the 
mechanism by which alcohol may affect the serum con-
centration calcidiol remains rather unknown. Some stud-
ies indicate that alcohol influences the serum concentration 
vitamin D indirectly through its effect on the expression 
of parathyroid hormone [59, 63, 64]. On the other hand, 
results from an animal study showed that alcohol results in 
CYP24A1 induction, an enzyme that breaks down calcidiol 
[65].
A limitation of this study is that only the serum concen-
tration calcidiol was measured and not serum 1,25-dihy-
droxycholecalciferol or vitamin D binding protein. Cal-
cidiol is considered to be the best indicator to monitor the 
vitamin D status, as 1,25-dihydroxycholecalciferol does not 
reflect vitamin D reserves or vitamin D status [37]. How-
ever, as the most active form of vitamin D, 1,25-dihydrox-
ycholecalciferol might reflect vitamin D activity during 
the initial phase of fracture healing better. A low vitamin 
D binding protein is found to compensate for a low serum 
concentration of calcidiol (deficiency) resulting in similar 
“net” concentrations of estimated bio-availability calcidiol 
[66]. Another study limitation was that the time until blood 
sampling ranged up to 85 days, although half of the samples 
were obtained within 7 days and 80 % within 11 days after 
the fracture. The majority of the cases with delayed blood 
sampling occurred in patients who were referred from other 
hospitals and some other cases were due to a delayed inclu-
sion in the study. These delayed blood samples may have 
resulted in a less accurate determination of the vitamin D 
status at the time of fracture, taking into account the cir-
culating half-life of calcidiol (2–3 weeks) and its metabo-
lization during the process of fracture healing. Vitamin D 
status should ideally be determined on the day of fracture. 
Another issue is that the percentage of women and mean 
age in the study group were somewhat higher compared to 
the non-participating patients, which may affect the gener-
alizability of the study results. These differences were most 
likely due to the fact that patients above the age of 50 years 
were routinely offered a screening for osteoporosis, and the 
proportion of women in this age category was higher.
In conclusion, we found 71 % of our adult fracture 
patients to have suboptimal levels of vitamin D, including 
40 % with vitamin D deficiency (calcidiol <50 nmol/L). 
Given the potential of vitamin D in fracture healing, cli-
nicians treating adult fracture patients should be aware of 
the frequent presence of vitamin D deficiency during the 
winter, especially in smoking and non-Caucasian patients. 
Research on the effect of vitamin D deficiency and supple-
mentation on fracture healing is needed, before suggesting 
routine monitoring or supplementation in all adult fracture 
patients or in selected groups.
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